Highlights the value of companion diagnostics in the drug industry and the effectiveness of ctDNA testing in blood samples instead of invasive tumor biopsies for patient screening in clinical trials, The assay demonstrated ctDNA liquid biopsy can be an alternative or complement to tissue…